In any event, the initial attempts of NPY gene therapy had limited relevance for clinical translation: they were all carried out before epilepsy onset, in a scenario that is obviously non-reproducible in real patients and that did not take into account the aberrant changes occurring during epileptogenesis, which may significantly affect treatment effectiveness. Here, NPY is linked to epilepsy.